However, DNMT3A mutations did not correlate with any variations in 5-mC content in AML genomes and were not associated with a specific methylation or gene expression signature in AML patients, so further evaluation is needed to better define the potential pathogenic role of these mutations [13, 14]. Here, DNMT3A is linked to acute myeloid leukemia.